Literature DB >> 33747512

Adaptive immunity to human coronaviruses is widespread but low in magnitude.

Hyon-Xhi Tan1, Wen Shi Lee1, Kathleen M Wragg1, Christina Nelson1, Robyn Esterbauer1, Hannah G Kelly1,2, Thakshila Amarasena1, Robert Jones3, Graham Starkey3, Bao Zhong Wang3, Osamu Yoshino3, Thomas Tiang3, Michael Lindsay Grayson4, Helen Opdam5,6, Rohit D'Costa7,8, Angela Vago3, Laura K Mackay1, Claire L Gordon1,4, Adam K Wheatley1, Stephen J Kent1,2,9, Jennifer A Juno1.   

Abstract

OBJECTIVES: Endemic human coronaviruses (hCoVs) circulate worldwide but cause minimal mortality. Although seroconversion to hCoV is near ubiquitous during childhood, little is known about hCoV-specific T-cell memory in adults.
METHODS: We quantified CD4 T-cell and antibody responses to hCoV spike antigens in 42 SARS-CoV-2-uninfected individuals. Antigen-specific memory T cells and circulating T follicular helper (cTFH) cells were identified using an activation-induced marker assay and characterised for memory phenotype and chemokine receptor expression.
RESULTS: T-cell responses were widespread within conventional memory and cTFH compartments but did not correlate with IgG titres. SARS-CoV-2 cross-reactive T cells were observed in 48% of participants and correlated with HKU1 memory. hCoV-specific T cells exhibited a CCR6+ central memory phenotype in the blood, but were enriched for frequency and CXCR3 expression in human lung-draining lymph nodes.
CONCLUSION: Overall, hCoV-specific humoral and cellular memory are independently maintained, with a shared phenotype existing among coronavirus-specific CD4 T cells. This understanding of endemic coronavirus immunity provides insight into the homeostatic maintenance of immune responses that are likely to be critical components of protection against SARS-CoV-2.
© 2021 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology Inc.

Entities:  

Keywords:  CD4 T cell; SARS‐CoV‐2; cTFH; coronavirus; hCoV; lymph node

Year:  2021        PMID: 33747512      PMCID: PMC7968850          DOI: 10.1002/cti2.1264

Source DB:  PubMed          Journal:  Clin Transl Immunology        ISSN: 2050-0068


  42 in total

Review 1.  T Follicular Helper Cell Biology: A Decade of Discovery and Diseases.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2019-05-21       Impact factor: 31.745

2.  Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion.

Authors:  Rimpei Morita; Nathalie Schmitt; Salah-Eddine Bentebibel; Rajaram Ranganathan; Laure Bourdery; Gerard Zurawski; Emile Foucat; Melissa Dullaers; SangKon Oh; Natalie Sabzghabaei; Elizabeth M Lavecchio; Marilynn Punaro; Virginia Pascual; Jacques Banchereau; Hideki Ueno
Journal:  Immunity       Date:  2011-01-06       Impact factor: 31.745

3.  A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood.

Authors:  Jennifer M Dan; Cecilia S Lindestam Arlehamn; Daniela Weiskopf; Ricardo da Silva Antunes; Colin Havenar-Daughton; Samantha M Reiss; Matthew Brigger; Marcella Bothwell; Alessandro Sette; Shane Crotty
Journal:  J Immunol       Date:  2016-06-24       Impact factor: 5.422

4.  Human coronavirus NL63 and 229E seroconversion in children.

Authors:  Ronald Dijkman; Maarten F Jebbink; Nawal Bahia El Idrissi; Krzysztof Pyrc; Marcel A Müller; Taco W Kuijpers; Hans L Zaaijer; Lia van der Hoek
Journal:  J Clin Microbiol       Date:  2008-05-21       Impact factor: 5.948

5.  CXCR3 directs antigen-specific effector CD4+ T cell migration to the lung during parainfluenza virus infection.

Authors:  Jacob E Kohlmeier; Tres Cookenham; Shannon C Miller; Alan D Roberts; Jan P Christensen; Allan R Thomsen; David L Woodland
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

6.  Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.

Authors:  Giuseppe Gerna; Giulia Campanini; Francesca Rovida; Elena Percivalle; Antonella Sarasini; Antonietta Marchi; Fausto Baldanti
Journal:  J Med Virol       Date:  2006-07       Impact factor: 2.327

7.  The dominance of human coronavirus OC43 and NL63 infections in infants.

Authors:  Ronald Dijkman; Maarten F Jebbink; Eleanor Gaunt; John W A Rossen; Kate E Templeton; Taco W Kuijpers; Lia van der Hoek
Journal:  J Clin Virol       Date:  2011-12-19       Impact factor: 3.168

8.  T-cell responses to MERS coronavirus infection in people with occupational exposure to dromedary camels in Nigeria: an observational cohort study.

Authors:  Chris Ka Pun Mok; Airu Zhu; Jingxian Zhao; Eric H Y Lau; Junxiang Wang; Zhao Chen; Zhen Zhuang; Yanqun Wang; Abeer N Alshukairi; Salim A Baharoon; Wenling Wang; Wenjie Tan; Weiwen Liang; Jamiu O Oladipo; Ranawaka A P M Perera; Sulyman A Kuranga; Malik Peiris; Jincun Zhao
Journal:  Lancet Infect Dis       Date:  2020-10-06       Impact factor: 25.071

9.  Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.

Authors:  Takuya Sekine; André Perez-Potti; Olga Rivera-Ballesteros; Kristoffer Strålin; Jean-Baptiste Gorin; Annika Olsson; Sian Llewellyn-Lacey; Habiba Kamal; Gordana Bogdanovic; Sandra Muschiol; David J Wullimann; Tobias Kammann; Johanna Emgård; Tiphaine Parrot; Elin Folkesson; Olav Rooyackers; Lars I Eriksson; Jan-Inge Henter; Anders Sönnerborg; Tobias Allander; Jan Albert; Morten Nielsen; Jonas Klingström; Sara Gredmark-Russ; Niklas K Björkström; Johan K Sandberg; David A Price; Hans-Gustaf Ljunggren; Soo Aleman; Marcus Buggert
Journal:  Cell       Date:  2020-08-14       Impact factor: 41.582

10.  Correlates of protection against SARS-CoV-2 in rhesus macaques.

Authors:  Katherine McMahan; Jingyou Yu; Noe B Mercado; Carolin Loos; Lisa H Tostanoski; Abishek Chandrashekar; Jinyan Liu; Lauren Peter; Caroline Atyeo; Alex Zhu; Esther A Bondzie; Gabriel Dagotto; Makda S Gebre; Catherine Jacob-Dolan; Zhenfeng Li; Felix Nampanya; Shivani Patel; Laurent Pessaint; Alex Van Ry; Kelvin Blade; Jake Yalley-Ogunro; Mehtap Cabus; Renita Brown; Anthony Cook; Elyse Teow; Hanne Andersen; Mark G Lewis; Douglas A Lauffenburger; Galit Alter; Dan H Barouch
Journal:  Nature       Date:  2020-12-04       Impact factor: 49.962

View more
  9 in total

1.  SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63.

Authors:  Bezawit A Woldemeskel; Caroline C Garliss; Joel N Blankson
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

2.  Immunological memory to common cold coronaviruses assessed longitudinally over a three-year period pre-COVID19 pandemic.

Authors:  Esther Dawen Yu; Tara M Narowski; Eric Wang; Emily Garrigan; Jose Mateus; April Frazier; Daniela Weiskopf; Alba Grifoni; Lakshmanane Premkumar; Ricardo da Silva Antunes; Alessandro Sette
Journal:  Cell Host Microbe       Date:  2022-07-20       Impact factor: 31.316

Review 3.  T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants.

Authors:  Thi H O Nguyen; Carolyn A Cohen; Louise C Rowntree; Maireid B Bull; Asmaa Hachim; Katherine Kedzierska; Sophie A Valkenburg
Journal:  Front Med (Lausanne)       Date:  2021-12-24

Review 4.  The intestinal microbiota and improving the efficacy of COVID-19 vaccinations.

Authors:  Jiezhong Chen; Luis Vitetta; Jeremy D Henson; Sean Hall
Journal:  J Funct Foods       Date:  2021-11-10       Impact factor: 4.451

5.  Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year period.

Authors:  Esther Dawen Yu; Tara M Narowski; Eric Wang; Emily Garrigan; Jose Mateus; April Frazier; Daniela Weiskopf; Alba Grifoni; Lakshmanane Premkumar; Ricardo da Silva Antunes; Alessandro Sette
Journal:  bioRxiv       Date:  2022-03-02

6.  HLA-dependent variation in SARS-CoV-2 CD8 + T cell cross-reactivity with human coronaviruses.

Authors:  Paul R Buckley; Chloe H Lee; Mariana Pereira Pinho; Rosana Ottakandathil Babu; Jeongmin Woo; Agne Antanaviciute; Alison Simmons; Graham Ogg; Hashem Koohy
Journal:  Immunology       Date:  2022-03-07       Impact factor: 7.215

Review 7.  Understanding COVID-19 Vaccines Today: Are T-cells Key Players?

Authors:  Areez Shafqat; Tarek Z Arabi; Belal N Sabbah; Humzah S Abdulkader; Shameel Shafqat; Adhil Razak; Junaid Kashir; Khaled Alkattan; Ahmed Yaqinuddin
Journal:  Vaccines (Basel)       Date:  2022-06-06

8.  SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection.

Authors:  Carolyn A Cohen; Athena P Y Li; Asmaa Hachim; David S C Hui; Mike Y W Kwan; Owen T Y Tsang; Susan S Chiu; Wai Hung Chan; Yat Sun Yau; Niloufar Kavian; Fionn N L Ma; Eric H Y Lau; Samuel M S Cheng; Leo L M Poon; Malik Peiris; Sophie A Valkenburg
Journal:  Nat Commun       Date:  2021-07-29       Impact factor: 14.919

9.  How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology.

Authors:  Naomi R Waterlow; Edwin van Leeuwen; Nicholas G Davies; Stefan Flasche; Rosalind M Eggo
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-07       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.